Test Directory

Test Code
1680
Test Name
Trichorhinophalangeal I Syndrome, Type / III
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
TRPS1
Description

TRPS1 related disorders - Trichorhinophalangeal syndrome type I (TRPS I; MIM 190350) and type III (TRPS III; MIM 190351) are allelic autosomal dominant disorders characterized by craniofacial and skeletal abnormalities. TRPS is characterized by slow growing, sparse scalp hair, laterally sparse eyebrows, a pear shaped nose with a bulbous tip, a long flat philtrum, a thin upper vermillion border, protruding ears, and postnatal, progressive growth retardation. Skeletal abnormalities include cone shaped epiphyses of the phalanges and other bones, shortening of the phalanges and metacarpals, hip malformations and short stature. The skeletal age lags behind the chronological age until puberty. Patients with TRPS III are more severely affected than those with TRPS I and are typically shorter and have more severe brachydactyly involving all tubular bones of the hands. They may also have additional skeletal abnormalities. TRPS I and TRPS III are caused by mutations in the zinc-finger transcription factor gene, TRPS1. TRPS1 haploinsufficiency is considered the major cause of TRPS I. TRPS III is typically caused by mutations resulting in substitutions in a specific DNA binding domain. It is proposed that these mutations exert a dominant negative effect.

Trichorhinophalangeal syndrome, type II (TRPS II) shares many clinical features with TRPS I and TRPS III; however, patients with TRPS II have multiple cartilaginous exostoses, mental retardation, and some may have microcephaly. TRPS II is a contiguous gene syndrome caused by the deletion of the TRPS1 and EXT1 genes.

Testing Schedule
Monday-Friday
Genes
TRPS1
MIM
190350, 190351
Disease Group
Craniosynostosis and Craniofacial Disorders, Hair and Nail disorders, Skeletal Disorders, Skin